i.KAPSEL® rTG Omega-3

i.KAPSEL® rTG Omega-3 is an advanced integrated delivery technology designed to optimize Omega-3 performance by combining a highly absorbable re-esterified triglyceride (rTG) form with a protective microencapsulation system. This innovative structure helps preserve EPA and DHA integrity, enhance oxidative stability, improve bioavailability, enable controlled release, and minimize unpleasant fishy taste and odor, ensuring efficient and optimized Omega-3 delivery.

  • Overview
  • Surpassing Challenges
  • Molecular Design Engineer
  • Mechanism Of Action
  • Features & Benefits
  • Pharmacokinetics

Technology Behind

i.KAPSEL® i.KAPSEL® rTG Omega-3 is an advanced integrated delivery technology designed to optimize Omega-3 performance by combining a highly absorbable re-esterified triglyceride (rTG) form with a protective microencapsulation system. This innovative structure helps preserve EPA and DHA integrity, enhance oxidative stability, improve bioavailability, enable controlled release, and minimize unpleasant fishy taste and odor, ensuring efficient and optimized Omega-3 delivery.

Cellular stress

Key Challenges

Surpassing Challenges 1

Oxidative Instability: EPA and DHA are highly susceptible to oxidation, which can compromise oil quality, stability, and potency.

Surpassing Challenges 1

Limited Bioavailability: Conventional omega-3 forms may exhibit lower absorption, limiting the amount of EPA and DHA available to the body

Surpassing Challenges 2

Unpleasant Taste and Odor: Fishy aftertaste, odor, and burps can negatively affect consumer acceptance and long-term compliance.

Surpassing Challenges 3

Low Active Concentration: Some conventional fish oil formulations contain relatively low levels of EPA and DHA, requiring larger doses to achieve the desired intake

Microencapsulation

Encapsulates microscopic EPA- and DHA-rich Omega-3 oil droplets within a protective maltodextrin matrix, helping shield them from oxidation and environmental stressors while supporting stability and controlled release.

Stressed Cell Visualization
Healthy Cell Visualization

Re-Esterified Triglyceride (rTG)

Re-esterified triglyceride (rTG) technology restructures Omega-3 fatty acids into a triglyceride form after purification and concentration. This form is designed to support efficient digestion and absorption

From Protection to Absorption

  • Protection: Microencapsulation shields EPA and DHA within a maltodextrin matrix, helping protect them against oxidation and degradation during gastric transit.
  • Release: The encapsulated Omega-3 gradually disperses in the intestinal environment, making EPA and DHA available for digestion.
  • Enhanced Absorption: The re-esterified triglyceride (rTG) form provides omega-3 fatty acids in a triglyceride structure that is efficiently digested and absorbed, supporting the intestinal uptake and subsequent transport of EPA and DHA into systemic circulation.

Stressed Cell Visualization

Enhanced Oxidative Stability

The protective maltodextrin matrix shields EPA and DHA from oxygen, light, and moisture, helping reduce oxidation and preserve omega-3 integrity during storage

Improved Bioavailability

Microencapsulation helps protect omega-3 fatty acids during gastric transit and supports their release in the intestinal environment, promoting EPA and DHA absorption.

Controlled Release

The microencapsulation system enables gradual dispersion of omega-3 fatty acids in the intestinal environment, helping protect EPA and DHA during gastric transit and supporting their availability for intestinal absorption.

Pharmacokinetics

....

No chart data available for this technology.

YOUR CART
Free shipping on orders over three items

Your cart is empty